The full name of Haitupopa is Haitupopa ethanolamine, which is usually taken for 1~2 weeks to see the effect. HaiTuPoPa ethanolamine can promote platelet generation, oral administration, blood concentration in 1~2 hours that there is a significant increase, but the human body to the drug response, began to hematopoietic and ultimately make the platelet elevation, it is necessary to take a period of time, generally ate 1~2 weeks you can see the platelet count rise. Haitupopa ethanolamine can be used to treat adult patients with chronic primary immune thrombocytopenia (ITP) who have had a poor response to previous treatment with glucocorticoids, immunoglobulins, etc. It can also be used to treat adult patients with severe aplastic anemia (SAA) who have had a poor response to immunosuppressive therapy (IST). Haitropopoethanolamine is an oral nonpeptide thrombopoietin receptor (TPO-R) agonist that promotes thrombopoiesis by activating the TPO-R-mediated STAT and MAPK signaling pathways. Platelet counts in patients with chronic primary immune thrombocytopenia can be elevated with the use of Hetropapa ethanolamine, and bleeding can be reduced or prevented. If the use of Hetropoxypal Ethanolamine is required, do so under the supervision of a physician.